「Middle East respiratory syndrome (MERS) 中東呼吸器症候群」の版間の差分
ナビゲーションに移動
検索に移動
Vaccipedia.admin (トーク | 投稿記録) (ページの作成:「{{Quote |content=Modjarrad K, Roberts C, Mills K, et. al. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-l…」) |
(相違点なし)
|
2019年12月23日 (月) 00:42時点における最新版
Modjarrad K, Roberts C, Mills K, et. al. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet Infectious Diseases. 2019;19(9):1013-1022. [cited 2019Oct11] Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(19)30266-X/fulltext |
MERSプラスミドワクチン phase 1